Navigation Links
DermTech Is Issued U.S. Patent for the Early Detection, Staging and Monitoring of Melanoma
Date:12/19/2007

LA JOLLA, Calif., Dec 19 /PRNewswire/ -- DermTech, Inc., a biotechnology company developing molecular diagnostics for the early detection of melanoma and other diseases, announced that it has been issued Patent No. 7,297,480 by the United States Patent and Trademark Office. The patent, entitled: "Method for Detection of Melanoma", includes claims focused on non-invasive methods for detecting early-stage melanoma and for staging, and claims for monitoring melanoma in a subject.

The patent claims the use of DermTech's "tape stripping" technology for the purposes of detecting, staging and monitoring melanoma. The methods claimed in the patent focus on the use of DermTech's EGIR (Epidermal Genetic Information Retrieval, a skin sampling technique known as "tape stripping" in combination with a molecular diagnostic assay). Specifically, adhesive tape is placed over a lesion suspicious for melanoma and then removed to harvest the top layer of skin cells. The RNA is extracted and analyzed to determine and compare the level of a key melanoma marker, Interleukin-2 Receptor 1 (IL-2 R1), with the level in a normal skin control sample. A decrease in IL-2 R1 is indicative of early-stage melanoma. The patent also claims the use of evaluating additional biomarkers based upon differences in gene expression such that a change in these messenger RNAs is indicative of late-stage melanoma. The ability to detect, stage and monitor disease is critical for improved clinical outcomes.

"DermTech welcomes the issuance of this patent as it will allow us to move forward and more fully develop and position our core EGIR technology for the staging as well as the detection, of melanoma," said George Schwartz, CEO, DermTech. "This patent is an important addition to our intellectual property portfolio."

The incidence rate of malignant melanoma is increasing faster than any other cancer. Treatment involves surgical excision of the primary lesion, and vigilant monitoring to detect recurrence. The methods for detecting malignant melanoma described in DermTech's newly issued patent can serve as the basis for therapeutic decisions, saving many lives and reducing costs by avoiding unnecessary excisions and biopsies.

About DermTech:

Headquartered in La Jolla, California, DermTech International is focused on the development and validation of molecular tests using specimens derived from the skin. The company's proprietary Epidermal Genetic Information Retrieval (EGIR) technology is in clinical studies to evaluate its potential as a non-invasive diagnostic for melanoma and other major diseases. It is also being studied in the context of tracking treatment efficacy for a variety of dermatologic and other conditions, including the effects of drugs on skin at the molecular level in advance of observable clinical results. DermTech is actively pursuing research using EGIR and its applications in the areas of melanoma, prostate cancer and various skin disorders, such as psoriasis. For additional information, visit http://www.dermtech.com

Contacts:

DermTech

George Schwartz

858.450.4222

For DermTech

Jennifer Larson

415.409.2729

jlarson@labfive.com


'/>"/>
SOURCE DermTech, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. DermTech Appoints BioStatistical Pioneer, John Quackenbush, Ph.D., as a Member of the Companys Scientific Advisory Board
2. Dynavax Issued Landmark Patent Covering Second-Generation TLR9 Agonists
3. Pressure BioSciences, Inc. Issued First Patent in Canada
4. Patent on Technology for the Delivery of Stem Cells to the Human Heart Issued to CellCyte Genetics Corp. of Washington
5. Neurobiological Technologies, Inc. (Nasdaq: NTII) Q1/08 Review Issued By Scimitar Equity Research, Inc.
6. VisEn Medical Files Action to Invalidate New Caliper Life Sciences Patent
7. Oncolytics Biotech Inc. Announces Issuance of 23rd U.S. Patent
8. CODA Genomics Announces Issuance of Optimized Synthetic Gene Production Patent
9. Forest Laboratories Announces Federal Appeals Court Upholds Lexapro(R) Patent Decision
10. Weil Gotshal Wins Major Victory for Applera; Secures Summary Judgment Invalidating Three Patents
11. Angiotech receives favourable patent decision from New Zealands Intellectual Property Office
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... ... December 08, 2016 , ... KBioBox llc ... to client demand KbioBox developed a sophisticated “3 click” gene dditing off target ... from KBioBox’s new website, https://www.kbiobox.com/ and powered by the company’s ...
(Date:12/8/2016)... ... December 08, 2016 , ... This CAST literature review and report looks ... authors focus on the economic effects in countries that are major global commodity exporters ... and the resultant risk of low level presence (LLP) puts large volumes of trade ...
(Date:12/8/2016)... 2016  HedgePath Pharmaceuticals, Inc. (OTCQX: HPPI), a ... plans to commercialize innovative therapeutics for patients with ... were approved for trading on the OTCQX U.S. ... OTCQX, effective today, under the ticker symbol "HPPI." ... companies must meet high financial standards, follow best ...
(Date:12/8/2016)... PHILADELPHIA , Dec. 8, 2016  Partnering to ... ecosystem, Ben Franklin Technology Partners of Southeastern ... Group ("IHG"), the parent company of Independence Blue Cross; ... today announced their intentions for a $6 million funding ... early-stage healthcare startups. Responding to a burgeoning ...
Breaking Biology Technology:
(Date:12/5/2016)... WASHINGTON , Dec. 5, 2016  The ... (NIJ), today published "Can CT Scans Enhance or ... examines the potential of supporting or replacing forensic ... a CT scan. In response to ... NIJ is exploring using CT scans as a ...
(Date:11/30/2016)... 2016  higi SH llc (higi) announced today ... national brands, industry thought-leaders and celebrity influencers looking ... for taking steps to live healthier, more active ... higi has built the largest self-screening health station ... people who have conducted over 185 million biometric ...
(Date:11/28/2016)... 28, 2016 "The biometric ... 16.79%" The biometric system market is in the ... the near future. The biometric system market is expected ... at a CAGR of 16.79% between 2016 and 2022. ... biometric technology in smartphones, rising use of biometric technology ...
Breaking Biology News(10 mins):